BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27566105)

  • 1. Identification and Validation of PCAT14 as Prognostic Biomarker in Prostate Cancer.
    Shukla S; Zhang X; Niknafs YS; Xiao L; Mehra R; Cieślik M; Ross A; Schaeffer E; Malik B; Guo S; Freier SM; Bui HH; Siddiqui J; Jing X; Cao X; Dhanasekaran SM; Feng FY; Chinnaiyan AM; Malik R
    Neoplasia; 2016 Aug; 18(8):489-99. PubMed ID: 27566105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential panel of four-long noncoding RNA signature in prostate cancer predicts biochemical recurrence-free survival and disease-free survival.
    Huang TB; Dong CP; Zhou GC; Lu SM; Luan Y; Gu X; Liu L; Ding XF
    Int Urol Nephrol; 2017 May; 49(5):825-835. PubMed ID: 28188414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
    Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
    Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
    Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
    Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
    Mehra R; Udager AM; Ahearn TU; Cao X; Feng FY; Loda M; Petimar JS; Kantoff P; Mucci LA; Chinnaiyan AM
    Eur Urol; 2016 Oct; 70(4):549-552. PubMed ID: 26724257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of seven long noncoding RNAs signature for prediction of biochemical recurrence in prostate cancer.
    Shao N; Zhu Y; Wan FN; Ye DW
    Asian J Androl; 2019; 21(6):618-622. PubMed ID: 30860081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
    Wang J; Cheng G; Li X; Pan Y; Qin C; Yang H; Hua L; Wang Z
    Tumour Biol; 2016 Jul; 37(7):9603-13. PubMed ID: 26797783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. lncRNA PCAT14 Is a Diagnostic Marker for Prostate Cancer and Is Associated with Immune Cell Infiltration.
    Yan Y; Liu J; Xu Z; Ye M; Li J
    Dis Markers; 2021; 2021():9494619. PubMed ID: 35003397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
    Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal regulation of long noncoding RNAs THBS4‑003 and THBS4 control migration and invasion in prostate cancer cell lines.
    Liu J; Cheng G; Yang H; Deng X; Qin C; Hua L; Yin C
    Mol Med Rep; 2016 Aug; 14(2):1451-8. PubMed ID: 27357608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Landscape of Prognostic Outlier Genes in High-Risk Prostate Cancer.
    Zhao SG; Evans JR; Kothari V; Sun G; Larm A; Mondine V; Schaeffer EM; Ross AE; Klein EA; Den RB; Dicker AP; Karnes RJ; Erho N; Nguyen PL; Davicioni E; Feng FY
    Clin Cancer Res; 2016 Apr; 22(7):1777-86. PubMed ID: 26631616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy.
    Geybels MS; Wright JL; Bibikova M; Klotzle B; Fan JB; Zhao S; Feng Z; Ostrander EA; Lin DW; Nelson PS; Stanford JL
    Clin Epigenetics; 2016; 8():97. PubMed ID: 27651837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.
    Zhang Y; Zhang P; Wan X; Su X; Kong Z; Zhai Q; Xiang X; Li L; Li Y
    Biomed Pharmacother; 2016 Oct; 83():936-941. PubMed ID: 27522256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel RNA in situ hybridization assay for the long noncoding RNA SChLAP1 predicts poor clinical outcome after radical prostatectomy in clinically localized prostate cancer.
    Mehra R; Shi Y; Udager AM; Prensner JR; Sahu A; Iyer MK; Siddiqui J; Cao X; Wei J; Jiang H; Feng FY; Chinnaiyan AM
    Neoplasia; 2014 Dec; 16(12):1121-7. PubMed ID: 25499224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
    Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
    Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-129 predicts prognosis and inhibits cell growth in human prostate carcinoma.
    Xu S; Yi XM; Zhang ZY; Ge JP; Zhou WQ
    Mol Med Rep; 2016 Dec; 14(6):5025-5032. PubMed ID: 27779679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
    Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
    Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients.
    Zhao R; Sun F; Bei X; Wang X; Zhu Y; Jiang C; Zhao F; Han B; Xia S
    Prostate; 2017 Jul; 77(10):1107-1117. PubMed ID: 28585762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
    Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.